Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Halozyme Therapeutics Inc Note 1.000 8/1
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $17M | 12M | 1.41 |
| 2025-06-30 | $16M | 14M | 1.14 |
| 2025-03-31 | $12M | 9.4M | 1.28 |
| 2024-12-31 | $5.8M | 5.3M | 1.08 |
| 2024-09-30 | $20M | 17M | 1.19 |
| 2024-06-30 | $15M | 13M | 1.11 |
| 2024-03-31 | $7.8M | 8.0M | 0.97 |
| 2023-12-31 | $3.1M | 3.4M | 0.93 |
| 2023-09-30 | $3.3M | 3.5M | 0.94 |
Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1
View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1